Bullish
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Analysts
Cogent Biosciences (NASDAQ:COGT) has received an average "Moderate Buy" rating from fourteen analysts, with a 1-year average price target of $43.45. W...